Written by Klarity Editorial Team
Published: Jun 1, 2026

If you’re a psychiatrist or PMHNP wondering whether you can manage anxiety patients entirely through telehealth — including prescribing controlled substances like benzodiazepines — the short answer is yes, absolutely. But as with everything in healthcare, the devil’s in the details: federal telemedicine flexibilities, state-specific prescribing rules, and your provider type all shape what you can do and how you get paid for it.
Let’s cut through the noise. This guide breaks down the current state of telehealth anxiety prescribing, the real differences between psychiatrist and PMHNP authority, what reimbursement actually looks like, and how joining a telepsychiatry platform can simplify your practice while expanding your patient reach.
The bottom line: As of early 2026, psychiatrists can prescribe controlled substances for anxiety — including Schedule IV benzodiazepines like alprazolam (Xanax) and clonazepam — via telehealth without an initial in-person visit. This is thanks to COVID-era telemedicine flexibilities that the DEA and HHS have extended through December 2026.
Before the pandemic, the Ryan Haight Act required at least one in-person exam before prescribing any controlled medication remotely. That rule was suspended in March 2020, and it’s stayed suspended. In 2024 alone, over 7 million controlled substance prescriptions were written via telemedicine under these flexibilities — proof that the model works and that patients depend on it.
The catch? These are still temporary rules. The DEA is expected to finalize permanent telemedicine prescribing regulations by late 2026. The agency has signaled these will likely include a special telemedicine registration or modified exam requirements, but the goal is to preserve access while adding safeguards. For now, you’re good to go — just stay alert for DEA announcements in the second half of 2026.
What this means for your practice: You can evaluate a new patient with generalized anxiety disorder over video, initiate an SSRI or start a low-dose benzodiazepine if indicated, and manage follow-ups entirely online. You’re practicing within the same standard of care as in-person — just document appropriately and ensure you’re meeting any state-specific requirements (more on that below).
Most states align with federal policy, but some add their own wrinkles. Here’s what you need to know for the major markets:
Florida law prohibits telehealth prescribing of Schedule II controlled substances… unless you’re treating a psychiatric disorder. That carve-out means you can prescribe stimulants for comorbid ADHD via telehealth if needed, and benzodiazepines (Schedule IV) have no telehealth restriction at all.
You must check Florida’s PDMP (E-FORCSE) before prescribing any controlled medication — this is mandatory statewide. Also note: if you’re an out-of-state provider with only Florida’s telehealth registration (not a full FL license), you cannot prescribe controlled substances remotely in Florida. Full licensure required for that.
Texas allows telehealth prescribing for psychiatric conditions but specifically bans treatment of chronic pain with controlled drugs via telemedicine. Anxiety doesn’t fall under ‘chronic pain,’ so you’re clear to prescribe anxiolytics remotely.
Texas requires checking the state PDMP (Texas PMP Aware) before any controlled prescription. Unlike some states, there’s no telehealth-specific quantity limit for physicians — that’s an advantage over some neighboring states. Texas is also part of the Interstate Medical Licensure Compact (IMLC), making it easier to get licensed if you’re expanding your telehealth footprint.
California imposes no unique telehealth prescribing restrictions beyond federal law. If you can do the evaluation via video (which satisfies California’s exam requirement), you can prescribe. The state has strong telehealth payment parity laws (AB 744), so private insurers must reimburse telehealth visits at the same rate as in-person for mental health services.
California doesn’t participate in IMLC yet, so out-of-state psychiatrists need a full CA license to treat California patients via telehealth.
No special telehealth prescribing limits. New York’s telehealth rules integrate virtual care into standard practice. One thing to watch: NY has one of the strictest PDMP mandates in the country — you must check the iSTOP database for every controlled substance prescription, no exceptions. It takes 30 seconds; just build it into your workflow.
Medicare patients in NY (and elsewhere) may need periodic in-person visits under a federal rule that’s been delayed through 2024-2025 — verify current Medicare policy, but enforcement has been postponed multiple times.
Neither state restricts telehealth prescribing for mental health beyond federal rules. Both mandate PDMP checks (PA’s ABC-MAP, Illinois’ PMP). Illinois has strong telehealth parity laws ensuring equal reimbursement, which helps financially. Pennsylvania’s telehealth landscape is less formalized legislatively, but providers follow professional board guidance and federal policy without issue.
The common thread: Check your state PDMP, document your telehealth encounter properly (note patient consent, confirm they’re in your licensed state during the visit), and practice within standard of care. For psychiatrists, the authority is broad — you can do what you’d do in person.
Here’s where it gets nuanced. Psychiatrists (MD/DO) have unrestricted prescribing authority in all 50 states — no supervision, no collaboration requirements, no formulary limits for anxiety medications. A PMHNP’s authority, however, depends entirely on where they’re licensed.
In about half of U.S. states, PMHNPs can evaluate, diagnose, and prescribe medications — including controlled substances — independently, with no physician oversight. These ‘Full Practice Authority’ (FPA) states treat PMHNPs essentially like psychiatrists in terms of scope.
Example FPA states: New York (as of 2022), Oregon, Washington, Arizona, Colorado, New Mexico.
New York’s 2022 breakthrough: New York eliminated its collaborative agreement requirement in April 2022. Now any NY-licensed PMHNP can open their own practice, manage anxiety patients, and prescribe benzodiazepines or SSRIs without a supervising psychiatrist. This opened the floodgates for NP-led telepsychiatry in one of the nation’s largest markets.
The other half of states require PMHNPs to have a formal relationship with a physician to prescribe. This can range from a written collaborative agreement (reduced practice) to direct supervision for all activities (restricted practice).
California (transitioning): Historically restricted, California’s AB 890 (2020) created a phased pathway to independence. As of January 2023, experienced NPs can practice without standardized physician procedures in certain group settings (103 NP designation). Starting January 2026, those NPs can apply for 104 NP status — full independent practice, including solo telehealth. New PMHNPs still operate under physician protocols until they qualify.
Texas (restricted): PMHNPs must have a Prescriptive Authority Agreement with a Texas physician. They can prescribe Schedule III-V medications (including benzodiazepines) if the physician delegates it, but cannot prescribe Schedule II controlled substances in outpatient settings (hospital/hospice only). For anxiety patients with comorbid ADHD who need a stimulant, the supervising psychiatrist would have to write that prescription.
Florida (restricted for psych): Florida allows certain experienced NPs to practice independently in primary care, but psychiatric NPs are excluded. PMHNPs still need a supervising physician and written protocol. The upside: Florida law exempts psychiatric NPs from the 7-day limit on controlled substances — you can prescribe a month of alprazolam for an anxiety disorder, unlike NPs in other specialties. Still, you need that physician collaboration on file.
Pennsylvania (restricted): Collaborative agreement required for the NP’s entire career. The physician must review a percentage of charts (100% for Schedule II prescriptions within 24 hours). For anxiety patients needing benzodiazepines, the NP can prescribe if it’s in their agreement, but the physician must be available for consult.
Illinois (reduced-to-full): Illinois offers a transition path. After 4,000 clinical hours + 250 CE hours, a PMHNP can apply for Full Practice Authority. Even then, Illinois requires a one-time physician attestation for prescribing certain controlled substances (benzos and Schedule II). Once that’s done, the NP can prescribe independently — but it’s not automatic from day one like it is for psychiatrists.
Benzodiazepines (Schedule IV — Xanax, Klonopin, Ativan) are the most common anxiety medications that trip up NP prescribing rules. In FPA states, PMHNPs can prescribe them freely. In restricted states, they need physician authorization via their collaborative agreement and a DEA registration (which itself may require physician sign-off in some states).
Schedule II stimulants (sometimes used off-label for treatment-resistant anxiety or comorbid ADHD) face even tighter restrictions. States like Texas and Florida limit NP prescribing of Schedule II to specific settings. Pennsylvania requires physician co-signature within 24 hours. This is where psychiatrists have a clear advantage — no such hoops.
The bottom line for PMHNPs: Know your state’s rules cold. If you’re in a restricted state and want to manage anxiety patients on a telehealth platform, you’ll likely need to partner with a supervising psychiatrist who’s comfortable with remote collaboration. Platforms like Klarity can help facilitate those relationships, but the legal requirement sits with you.
Let’s talk money — because if you’re joining a telehealth platform or considering a shift to virtual anxiety care, you need to know the economics.
Medicare pays psychiatrists surprisingly well for medication management:
These are national averages; they adjust slightly by geographic locality. Medicare’s telehealth parity has been extended through at least 2024-2025 (and likely into 2026 based on recent legislation), meaning virtual visits pay the same as in-person.
One Medicare hitch to watch: there was a rule requiring patients to have an in-person visit within 6 months for tele-mental health services post-PHE. Enforcement keeps getting delayed — it’s not in effect as of early 2026, but verify current policy if you’re building a Medicare-heavy practice.
Medicaid pays roughly 50-60% of Medicare rates, which means:
Lower rates, yes — but Medicaid volume can be high, especially for anxiety (which often correlates with lower socioeconomic status). Many states have expanded Medicaid telehealth coverage permanently post-COVID, and payment parity laws in states like Illinois ensure you’re not penalized for virtual visits.
Private payers typically reimburse at 100-150% of Medicare rates, depending on your contract and region. A 99213 med check might pay $100-130 from a major commercial plan. Telehealth parity laws in California, Illinois, and New York require private insurers to pay the same for telehealth as in-person mental health services — a huge win for telepsychiatrists.
Here’s the kicker: Medicare (and many insurers) reimburse PMHNPs at 85% of the physician fee schedule. If a psychiatrist gets $100 for a visit, an NP gets $85 for the exact same service. This isn’t a quality judgment — it’s CMS policy.
Some practices use ‘incident to’ billing (billing the NP’s service under the supervising physician’s NPI at 100%) to close this gap, but that’s generally not feasible in psychiatry or telehealth because ‘incident to’ requires the physician to be on-site and actively involved in care.
For telehealth platforms, this 15% difference matters when setting provider compensation or assigning patient panels. PMHNPs typically have lower salary expectations than psychiatrists, which can balance out the reimbursement delta — but it’s something to understand.
Use time-based coding when it works in your favor. Since 2021, E/M codes can be billed based on total time spent on the encounter date (including documentation), not just face-to-face time. A 15-minute video visit plus 10 minutes documenting after can justify a 99214 if you hit 25 minutes total.
For medication management, you’re typically using 99213 or 99214. If you’re also doing therapy, use the psychotherapy add-on codes (90833 for 30 min, 90836 for 45 min). Document appropriately — note symptoms reviewed, medication efficacy, side effects discussed, treatment plan.
Telehealth visits are audited like in-person visits, so proper documentation protects you. Note patient consent for telehealth, confirm their location (must be in a state where you’re licensed), and document the encounter was conducted via secure video.
Let’s be honest: if you’re a solo psychiatrist or PMHNP trying to build an anxiety-focused practice, DIY patient acquisition is expensive, slow, and often ineffective.
Here’s the reality behind common marketing channels:
What it promises: Rank on Google for ‘anxiety psychiatrist near me’ and patients will find you organically.
The reality: SEO takes 6-12 months of consistent investment before you see meaningful patient flow. You’ll need to:
Most solo providers don’t have the budget, expertise, or patience for this timeline. And even if it works, you’re still handling all the lead qualification yourself — plenty of clicks, fewer actual bookings.
What it promises: Instant visibility for mental health keywords.
The reality: Mental health keywords cost $15-40+ per click, and most clicks don’t convert to booked patients. A realistic cost per booked patient through PPC is $200-400+ when you factor in:
You could spend $3,000-5,000/month on Google Ads and still struggle to fill your schedule consistently.
What they promise: Get listed where patients are searching.
The reality:
Directories can work as part of a marketing mix, but they’re not a silver bullet — and the monthly fees are ongoing whether you get patients or not.
When you add it all up — agency fees, ad spend, directory subscriptions, staff time to handle leads, no-show rates, months of investment before ROI — you’re typically spending $200-500+ to acquire a qualified psychiatric patient who actually shows up for their first appointment.
And that’s if you get it right. Most providers waste thousands on channels that don’t work before finding what does.
This is where a platform like Klarity Health fundamentally changes the economics.
Instead of gambling on marketing channels with uncertain ROI, Klarity uses a pay-per-appointment model for new patient leads. Here’s how it works:
No upfront marketing spend. No monthly subscription fees. No agency retainers. You only pay when a pre-qualified patient books an appointment with you.
What ‘pre-qualified’ means:
What you get:
You control your schedule. Set your availability, accept or decline patients as you see fit. If you want to work 10 hours a week or 40, you can. The platform scales with you.
Let’s compare the real cost of patient acquisition:
DIY Marketing:
Klarity:
For most providers — especially those starting out, scaling a practice, or adding telehealth — the platform model removes all the risk. You’re trading a small per-patient fee for predictable patient flow, zero wasted marketing spend, and infrastructure you’d otherwise have to build yourself.
This isn’t about being ‘lazy’ with marketing. It’s about smart economics: why spend $5,000/month hoping to fill your schedule when you can pay only when patients actually show up?
If you’re licensed in multiple states (or considering adding licenses), understanding each state’s regulatory environment helps you maximize your telehealth reach.
New York: Full practice authority for PMHNPs, strong telehealth parity laws, high demand (psychiatrist ratio 1:2,913 is among the best, but still not enough). Large Medicaid population. Good market for both MDs and NPs.
California: Massive market (40M people), telehealth parity for private insurance, AB 890 opening NP independence pathways. High commercial insurance penetration means better reimbursement than Medicaid-heavy states. Worth the licensure investment.
Texas: Huge psychiatrist shortage (1:8,966 ratio), growing telehealth adoption, but more restrictive NP rules. If you’re a psychiatrist, Texas is wide open. If you’re a PMHNP, you’ll need a collaborating physician.
Florida: Similar shortage (1:8,577 ratio), allows telehealth prescribing of psychiatric meds including Schedule II, but PMHNPs need physician collaboration. Fast-growing retiree population with anxiety and depression creates steady demand.
The Interstate Medical Licensure Compact (IMLC) makes it easier for physicians to get licensed in multiple states through an expedited process. Texas, Illinois, and Pennsylvania participate; California and New York don’t.
If you’re a psychiatrist looking to expand your telehealth footprint, IMLC states are low-hanging fruit. PMHNPs have the Nurse Licensure Compact (NLC) for some states, but it doesn’t include the big markets (CA, NY, TX, FL, PA all require separate NP licenses).
Strategy: Prioritize licenses in high-population, FPA states if you’re an NP (NY, AZ, OR). Prioritize shortage states with good reimbursement if you’re an MD (TX, FL, CA, IL).
Can psychiatrists prescribe benzodiazepines via telehealth in 2026?Yes. Federal telemedicine flexibilities extended through December 2026 allow psychiatrists to prescribe Schedule IV controlled substances (including Xanax, Klonopin, Ativan) via telehealth without an initial in-person visit. State PDMP checks still required.
Can PMHNPs prescribe anxiety medication independently?It depends on the state. In Full Practice Authority states (New York, Arizona, Oregon, etc.), yes — PMHNPs can prescribe all anxiety medications including controlled substances independently. In reduced/restricted states (Texas, Florida, Pennsylvania, California pre-2026), they need physician collaboration or supervision.
Do I need a DEA registration to prescribe anxiety meds via telehealth?Yes, if you’re prescribing controlled substances (benzodiazepines). You need a DEA registration in the state where you’re licensed and practicing. The DEA number must match the state license.
What’s the difference between 90792 and 99213 for billing?90792 is the code for an initial psychiatric diagnostic evaluation (typically 60+ minutes, ~$202 Medicare reimbursement). 99213 is a standard 15-minute established patient visit for medication management (~$95 Medicare). Use 90792 for new patients or comprehensive re-evaluations; use 99213/99214 for routine med checks.
Does Medicare pay the same for telehealth as in-person?As of early 2026, yes — Medicare telehealth parity has been extended through at least 2024-2025 and likely into 2026. Virtual mental health visits reimburse at the same rate as in-person. Watch for a potential in-person visit requirement (enforcement keeps getting delayed).
Can I prescribe across state lines via telehealth?Only if you’re licensed in the state where the patient is located during the visit. You can’t see a Texas patient with only a California license, even if it’s telehealth. Multi-state licensure (via IMLC for MDs, or individual state licenses for NPs) is required.
What states have the most restrictive PMHNP prescribing rules for anxiety?Texas (requires physician delegation, bans outpatient Schedule II prescribing by NPs), Florida (requires physician protocol, though psych NPs get exemptions for controlled substance limits), Pennsylvania (requires collaborative agreement for entire career, physician must review Schedule II prescriptions within 24 hours).
How do I check a state’s PDMP before prescribing?Each state has its own Prescription Drug Monitoring Program database:
You register as a provider, then query the patient’s name/DOB before prescribing. Most states mandate this check; document it in your chart note.
Here’s the reality: building a thriving telehealth anxiety practice through DIY marketing is possible — but it’s expensive, slow, and uncertain. You’re gambling thousands of dollars and months of time hoping to fill your schedule.
Klarity Health offers a different path:
Whether you’re a psychiatrist with full prescribing authority or a PMHNP navigating state collaboration requirements, Klarity handles the patient acquisition and technology so you can focus on what you do best: treating anxiety.
Explore the Klarity provider network and see how the platform can help you scale your practice with predictable patient flow and zero wasted marketing dollars. Because you didn’t go into psychiatry to become a marketing expert — you went into it to help people feel better.
HHS Press Release – ‘HHS & DEA Extend Telemedicine Flexibilities through 2026’ (hhs.gov). Published January 2, 2026. Official government source confirming federal telehealth prescribing policy extension. www.hhs.gov/press-room/dea-telemedicine-extension-2026.html
Florida Statutes §464.012 and §456.47 – Nurse Practice Act & Telehealth (flsenate.gov). 2024 Statutes (effective 2024-25). State law text defining NP scope and telehealth rules in Florida. www.flsenate.gov/laws/statutes/2024/464.012 and www.flsenate.gov/laws/statutes/2022/456.47
California Board of Registered Nursing – AB 890 Implementation FAQs (rn.ca.gov). Updated 2024. State regulatory guidance on new NP independent practice categories. rn.ca.gov/practice/ab890.shtml
NPNY Announcement – ‘NP Modernization Act Passes in NY’ (npny.enpnetwork.com). Published April 9, 2022. Professional association announcement outlining changes in New York law. npny.enpnetwork.com/nurse-practitioner-news/216175-breaking-news-np-modernization-act-passes
TheraThink – ‘Insurance Reimbursement Rates for Psychiatrists [2026]’ (therathink.com). Published 2025 (rates for 2026). Aggregates CMS data for psychiatric billing and Medicare reimbursement rates. therathink.com/insurance-reimbursement-rates-for-psychiatrists
Find the right provider for your needs — select your state to find expert care near you.